Recommencement of anticoagulation/antiplatelet therapy following non-operative management of a Chronic Subdural Hematoma – Is there an optimal time frame?

BACKGROUND: There is no consensus among clinicians regarding recommencement of antithrombotic agents following conservative management of a Chronic Subdural Hematoma (cSDH). Thus, the primary objective of this study was to determine the most commonly recommended interval and whether the data reveal...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Savan, George, K. Joshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492416/
https://www.ncbi.nlm.nih.gov/pubmed/34621571
http://dx.doi.org/10.25259/SNI_467_2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492416/
https://www.ncbi.nlm.nih.gov/pubmed/34621571
http://dx.doi.org/10.25259/SNI_467_2021

Ejemplares similares